Logo image of FXLV

F45 TRAINING HOLDINGS INC (FXLV) Stock Fundamental Analysis

NYSE:FXLV - New York Stock Exchange, Inc. - US30322L1017 - Common Stock - Currency: USD

0.0975  +0 (+1.46%)

After market: 0.0975 0 (0%)

Fundamental Rating

2

Taking everything into account, FXLV scores 2 out of 10 in our fundamental rating. FXLV was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of FXLV have multiple concerns. FXLV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FXLV has reported negative net income.
FXLV had a negative operating cash flow in the past year.
FXLV Yearly Net Income VS EBIT VS OCF VS FCFFXLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 -50M -100M -150M

1.2 Ratios

The profitability ratios for FXLV are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FXLV Yearly ROA, ROE, ROICFXLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 -50 -100

1.3 Margins

With an excellent Gross Margin value of 71.36%, FXLV belongs to the best of the industry, outperforming 82.98% of the companies in the same industry.
FXLV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FXLV Yearly Profit, Operating, Gross MarginsFXLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 50 -50 -100

2

2. Health

2.1 Basic Checks

FXLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
FXLV has more shares outstanding than it did 1 year ago.
There is no outstanding debt for FXLV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FXLV Yearly Shares OutstandingFXLV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M 80M
FXLV Yearly Total Debt VS Total AssetsFXLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

FXLV has an Altman-Z score of -2.51. This is a bad value and indicates that FXLV is not financially healthy and even has some risk of bankruptcy.
FXLV has a Altman-Z score of -2.51. This is amonst the worse of the industry: FXLV underperforms 90.07% of its industry peers.
A Debt/Equity ratio of 2.08 is on the high side and indicates that FXLV has dependencies on debt financing.
FXLV has a Debt to Equity ratio of 2.08. This is comparable to the rest of the industry: FXLV outperforms 53.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.08
Debt/FCF N/A
Altman-Z -2.51
ROIC/WACCN/A
WACC10.16%
FXLV Yearly LT Debt VS Equity VS FCFFXLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 100M -100M 200M -200M

2.3 Liquidity

FXLV has a Current Ratio of 1.61. This is a normal value and indicates that FXLV is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.61, FXLV is doing good in the industry, outperforming 73.05% of the companies in the same industry.
FXLV has a Quick Ratio of 1.61. This is a bad value and indicates that FXLV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, FXLV is in line with its industry, outperforming 49.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.97
FXLV Yearly Current Assets VS Current LiabilitesFXLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

FXLV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.74%, which is quite impressive.
FXLV shows a strong growth in Revenue. In the last year, the Revenue has grown by 89.68%.
EPS 1Y (TTM)68.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.67%
Revenue 1Y (TTM)89.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.91%

3.2 Future

Based on estimates for the next years, FXLV will show a very strong growth in Earnings Per Share. The EPS will grow by 31.16% on average per year.
The Revenue is expected to grow by 11.22% on average over the next years. This is quite good.
EPS Next Y32.61%
EPS Next 2Y48.54%
EPS Next 3Y31.16%
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y-2.44%
Revenue Next 3Y11.22%
Revenue Next 5YN/A

3.3 Evolution

FXLV Yearly Revenue VS EstimatesFXLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 50M 100M 150M
FXLV Yearly EPS VS EstimatesFXLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0 -0.5 -1

4

4. Valuation

4.1 Price/Earnings Ratio

FXLV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 0.33, which indicates a rather cheap valuation of FXLV.
100.00% of the companies in the same industry are more expensive than FXLV, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.70. FXLV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.33
FXLV Price Earnings VS Forward Price EarningsFXLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FXLV Per share dataFXLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FXLV's earnings are expected to grow with 31.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.54%
EPS Next 3Y31.16%

0

5. Dividend

5.1 Amount

No dividends for FXLV!.
Industry RankSector Rank
Dividend Yield N/A

F45 TRAINING HOLDINGS INC

NYSE:FXLV (8/24/2023, 8:04:01 PM)

After market: 0.0975 0 (0%)

0.0975

+0 (+1.46%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-14 2023-08-14/amc
Earnings (Next)11-15 2023-11-15/amc
Inst Owners0.05%
Inst Owner Change1.25%
Ins Owners51.4%
Ins Owner Change0%
Market Cap9.49M
Analysts78
Price Target3.06 (3038.46%)
Short Float %0.21%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2040.84%
Min EPS beat(2)-3699.02%
Max EPS beat(2)-382.67%
EPS beat(4)1
Avg EPS beat(4)-1035.17%
Min EPS beat(4)-3699.02%
Max EPS beat(4)19.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-12.58%
Min Revenue beat(2)-39.33%
Max Revenue beat(2)14.16%
Revenue beat(4)1
Avg Revenue beat(4)-7.64%
Min Revenue beat(4)-39.33%
Max Revenue beat(4)14.16%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.29%
PT rev (3m)-14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.33
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)0.3
Fwd EY303.38%
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS1.76
BVpS0.44
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.36%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 2.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 279.16%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 0.97
Altman-Z -2.51
F-Score1
WACC10.16%
ROIC/WACCN/A
Cap/Depr(3y)178.65%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.67%
EPS Next Y32.61%
EPS Next 2Y48.54%
EPS Next 3Y31.16%
EPS Next 5YN/A
Revenue 1Y (TTM)89.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.91%
Revenue Next Year-1.55%
Revenue Next 2Y-2.44%
Revenue Next 3Y11.22%
Revenue Next 5YN/A
EBIT growth 1Y50.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year174.78%
EBIT Next 3Y90.94%
EBIT Next 5YN/A
FCF growth 1Y-107.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.33%
OCF growth 3YN/A
OCF growth 5YN/A